TrialEuropean journal of clinical pharmacology2005
Safety, pharmacodynamics, and pharmacokinetics of BAY 59-7939--an oral, direct Factor Xa inhibitor--after multiple dosing in healthy male subjects.
Dagmar Kubitza et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
178 papers cite itlatest 60 shown
this paperpooled ittrialcites it